Capricor Inc.

Nasdaq CAPR · San Diego, CA

Works in Cardiovascular · Genetic & rare · Infectious disease · Musculoskeletal · Neurology · Respiratory

Capricor Inc. is a clinical trial sponsor based in San Diego, CA, listed as Nasdaq CAPR. It has 2 active clinical trials with 119 planned participants, across 6 therapeutic areas. Since 2021 it has completed 4 trials and stopped 1 early. Its FDA record on file shows compliance actions.

Trial track record · since 2021

2Active trials119 planned participants
4Completed6 with results posted
1Stopped early20% of finished trials

FDA record

0InspectionsNone posted since 2025
0Warning lettersNone on file
0RecallsNone on file

Recent FDA actions

Financials · Nasdaq CAPR

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

Pipeline · 2 active trials

StageTrialStatus

Questions about Capricor Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-22.

The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.

Approve Suite is not affiliated with Capricor Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.